| 1 |
34182131 | Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A2 is unrestrained. | 2021 Aug |
1 |
| 2 |
32251451 | Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer. | 2020 |
2 |
| 3 |
32592197 | Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin. | 2020 Aug |
1 |
| 4 |
30017554 | COX-1 mediates IL-33-induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity. | 2019 Mar |
1 |
| 5 |
31442897 | Evaluation of commonly used tests to measure the effect of single-dose aspirin on mouse hemostasis. | 2019 Oct |
1 |
| 6 |
31469551 | Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex. | 2019 Sep 24 |
2 |
| 7 |
27998883 | Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1. | 2017 Feb |
1 |
| 8 |
27074574 | Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. | 2016 May 31 |
1 |
| 9 |
25591798 | Selective cyclooxygenase-1 inhibition by p6 and gastrotoxicity: preliminary investigation. | 2015 |
2 |
| 10 |
23240590 | Female, but not male, mice show delayed cutaneous wound healing following aspirin administration. | 2013 Feb |
1 |
| 11 |
22366248 | NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. | 2012 Mar 16 |
1 |
| 12 |
16326168 | Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. | 2006 Jan |
1 |
| 13 |
16614756 | Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. | 2006 May |
1 |
| 14 |
14592546 | COX-1 and COX-3 inhibitors. | 2003 Jun 15 |
2 |
| 15 |
11964481 | Role of prostacyclin in the cardiovascular response to thromboxane A2. | 2002 Apr 19 |
1 |
| 16 |
11180504 | Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. | 2001 Feb |
2 |
| 17 |
11457426 | Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. | 2001 Jul 20 |
1 |
| 18 |
11745453 | Is COX-2 inhibition a panacea for cancer prevention? | 2001 Dec 1 |
1 |
| 19 |
10692466 | Spatial requirements for 15-(R)-hydroxy-5Z,8Z,11Z, 13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. Why acetylated COX-1 does not synthesize 15-(R)-hete. | 2000 Mar 3 |
2 |
| 20 |
10970676 | The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia. | 2000 Sep |
1 |
| 21 |
11195467 | Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. | 2000 Dec |
2 |
| 22 |
10339595 | Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. | 1999 May 25 |
1 |
| 23 |
9535546 | Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. | 1998 Feb |
2 |
| 24 |
9850065 | Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. | 1998 Dec 1 |
1 |